Spots Global Cancer Trial Database for A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer
Official Title: A Randomized, Open-label, Parallel Controlled, Multi-center Phase III Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Chemotherapy as Second-line Treatment in Subjects With Advanced Biliary Cancer
Study ID: NCT04809142
Conditions
Study Description
Brief Summary: This study is a randomized, parallel controlled, multicentre phase III clinical trial to evaluate the efficacy and safety of TQB2450 combined with anlotinib versus chemotherapy as second-line treatment in subjects with advanced biliary cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Anhui Provincal Hospital, Hefei, Anhui, China
Beijing Chao-Yang Hospital,Capital Medical University, Beijing, Beijing, China
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
Peking University People's Hospital, Beijing, Beijing, China
Beijing Youan Hospital,Captical Medical University, Beijing, Beijing, China
Beijing Cancer Hospital, Beijing, Beijing, China
Beijing Tsinghua Changgung Hospital, Beijing, Beijing, China
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Affiliated Hospital of Hebei University, Baoding, Hebei, China
Cangzhou Central Hospital, Cangzhou, Hebei, China
Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China
Harbin Medical University Affiliated Tumor Hospital, Harbin, Heilongjiang, China
Henan Tumor Hospital, Zhengzhou, Henan, China
Tongji Medical College of HUST, Wuhan, Hubei, China
Hunan Provincial People's Hospital, Changsha, Hunan, China
The First Peoples Hospital of Changzhou, Changzhou, Jiangsu, China
The First Bethune Hospital of Jilin University, Changchun, Jilin, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
